Type 2 Diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy individuals obese individuals individuals with impaired glucose tolerance and patients with Type 2 Diabetes Mellitus. 2.Ages between 18 and 80 years old. 3.Participants are informed and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Type 1 Diabetes Mellitus 2.Patients with severe primary diseases of the liver kidneys cardiovascular system hematopoietic system endocrine system etc. (those whose severity prevents them from completing the trial) 3.Progressive difficulty swallowing and swallowing pain persistent vomiting unintentional weight loss 4.Those taking medications such as glucocorticoids that significantly affect blood sugar levels 5.Those who have taken drugs affecting salivary secretion within the last 2 weeks (e.g. anticholinergics and anticholinesterase drugs) 6.Patients with mental illnesses who lack insight and cannot express themselves accurately 7.Pregnant and lactating women 8.Those who have recently or are currently participating in other drug clinical trials or taking medications that may affect the assessment of the trial drug's efficacy (those who have taken antibiotics within 1 month) 9.Suspected or confirmed history of alcohol or drug abuse 10.Those whom the investigator deems unsuitable for participation in the clinical trial based on the investigator's judgment including other conditions that may reduce the likelihood of enrollment or complicate it such as frequently changing work environments that may lead to loss to follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Glucose;Blood Lipids;tongue image; | — |
Countries
China
Contacts
No. 16 Airport Road Guangzhou University of Chinese Medicine First Affiliated Hospital